BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Darvishi N, Rahimi K, Mansouri K, Fathi F, Menbari MN, Mohammadi G, Abdi M. MiR-646 prevents proliferation and progression of human breast cancer cell lines by suppressing HDAC2 expression. Mol Cell Probes 2020;53:101649. [PMID: 32777446 DOI: 10.1016/j.mcp.2020.101649] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Li N, Chen XJ, Zeng YH, Zeng LP, Hu K, Chen LJ. Silencing of lncRNA CRNDE attenuates nonsmall-cell lung cancer progression by mediating the miR-455-3p/HDAC2 axis. Kaohsiung J Med Sci 2022. [PMID: 35611803 DOI: 10.1002/kjm2.12558] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Yu P, Wei K, Zhang T, Tan Z, Zhao H, Sun H. CircTMCO3 Promotes Gastric Cancer Progression by Regulating miR-577/RAB14 Axis. Cancer Manag Res 2021;13:6079-88. [PMID: 34377026 DOI: 10.2147/CMAR.S300559] [Reference Citation Analysis]
3 Shetty A, Venkatesh T, Kabbekodu SP, Tsutsumi R, Suresh PS. LncRNA-miRNA-mRNA regulatory axes in endometrial cancer: a comprehensive overview. Arch Gynecol Obstet 2022. [PMID: 35182183 DOI: 10.1007/s00404-022-06423-5] [Reference Citation Analysis]
4 Chen S, Zhou L, Ran R, Huang J, Zheng Y, Xing M, Cai Y. Circ_0016760 accelerates non-small-cell lung cancer progression through miR-646/AKT3 signaling in vivo and in vitro. Thorac Cancer 2021;12:3223-35. [PMID: 34658165 DOI: 10.1111/1759-7714.14191] [Reference Citation Analysis]
5 Barznegar M, Rahimi K, Mahdavi P, Menbari MN, Darvishi N, Vahabzadeh Z, Hakhamaneshi MS, Andalibi P, Abdi M. Relation between the circular and linear form of the Elongator Acetyltransferase Complex Subunit 3 in the progression of triple-negative breast cancer. Cell Biochem Funct 2022. [PMID: 35722999 DOI: 10.1002/cbf.3724] [Reference Citation Analysis]
6 Rahmani G, Sameri S, Abbasi N, Abdi M, Najafi R. The clinical significance of histone deacetylase-8 in human breast cancer. Pathol Res Pract 2021;220:153396. [PMID: 33691240 DOI: 10.1016/j.prp.2021.153396] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Wang B, Lu Y, Feng E. hsa_circ_0001610 knockdown modulates miR-646-STAT3 axis to suppress endometrial carcinoma progression. J Gene Med 2021;23:e3337. [PMID: 33822442 DOI: 10.1002/jgm.3337] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Cai X, Deng J, Zhou J, Cai H, Chen Z. Cyclin-dependent kinase 19 upregulation correlates with an unfavorable prognosis in hepatocellular carcinoma. BMC Gastroenterol 2021;21:377. [PMID: 34649520 DOI: 10.1186/s12876-021-01962-8] [Reference Citation Analysis]
9 Wang J, Ouyang S, Zhao S, Zhang X, Cheng M, Fan X, Cai Y, Liao L. SP1-Mediated Upregulation of circFAM126A Promotes Proliferation and Epithelial-Mesenchymal Transition of Oral Squamous Cell Carcinoma via Regulation of RAB41. Front Oncol 2022;12:715534. [DOI: 10.3389/fonc.2022.715534] [Reference Citation Analysis]
10 Huseinovic A, Jaspers A, van Splunter AP, Sørgård H, Wilting SM, Swarts DRA, van der Meulen IH, van Beusechem VW, de Menezes RX, Steenbergen RDM. Functional Screen for microRNAs Suppressing Anchorage-Independent Growth in Human Cervical Cancer Cells. Int J Mol Sci 2022;23:4791. [PMID: 35563182 DOI: 10.3390/ijms23094791] [Reference Citation Analysis]
11 Villegas-mirón P, Gallego A, Bertranpetit J, Laayouni H, Espinosa-parrilla Y. Signatures of genetic variation in human microRNAs point to processes of positive selection and population-specific disease risks. Hum Genet. [DOI: 10.1007/s00439-021-02423-8] [Reference Citation Analysis]
12 Ma F, Huang J, Li W, Li P, Liu M, Xue H. MicroRNA-455-3p functions as a tumor suppressor by targeting HDAC2 to regulate cell cycle in hepatocellular carcinoma. Environ Toxicol 2022. [PMID: 35286011 DOI: 10.1002/tox.23516] [Reference Citation Analysis]
13 Rahbari R, Rahimi K, Rasmi Y, Khadem-Ansari MH, Abdi M. miR-589-5p Inhibits Cell Proliferation by Targeting Histone Deacetylase 3 in Triple Negative Breast Cancer. Arch Med Res 2022;53:483-91. [PMID: 35840467 DOI: 10.1016/j.arcmed.2022.06.006] [Reference Citation Analysis]
14 Rahbari R, Rasmi Y, Khadem-Ansari MH, Abdi M. The role of histone deacetylase 3 in breast cancer. Med Oncol 2022;39:84. [PMID: 35578147 DOI: 10.1007/s12032-022-01681-4] [Reference Citation Analysis]